Projects and grants
prof. Tomáš Zima, MD, PhD, MBA:
IGA MZ ČR NT 11176-6 (2010 – 2014) Asociation of plateletes gene polymorphism with athretrombosis in patiens with venous tromboembolism - (co-investigator)
IGA MZ ČR NT 11210-4 (2010 – 2014) Influence of centrifugal pump on systemic inflammatory response and changes of blood elements in extracorporal circulation with deep hypothermia -( (co-investigator)
GA UK - 59410 (2010 – 2011) Monitoring of correlation of circulating tumour cells in blood (CTC) and disseminated tumour cells (DTC) in bone marrow in patients with primary breast carcinoma (co-investigator)
IGA MZ ČR NS10043-4/2008 Genetic predisposition and new biochemical markers of cardiovascular risk in patiens with chronic kidney diseases (co-investigator)
SVV-2010-260512 (2011): Regulatory mechanisms in pathogenesis of inflammatory and tumour diseases (co-investigator)
grant MPO FR-TI3/666, Assesment of pannel of new tumour markers in selected malignant diseases (co-investigator)
project BBMRI_CZ – development of Czech part of EU scientific infrastructure – Development and service of network of biological material banks for biomedical research. Responsible person
Research projects
prof. Tomáš Zima, MD, PhD, MBA:
RVO VFN 00064165: Diagnostics and treatment of genetic determinated diseases
VZ MSM002160849 (2007-2013) Neuropsychiatric aspects of neurodegenerative diseases
VZ MSM0021620807 – Metabolic, endocrine a genetic aspects of prevention, diagnotics and therapy of cardiovascular, cerebrovascular and renovascular diseases
PRVOUK P25/UK/1.LF UK – Complications of metabolic diseases
Springer D., Uhrová J.:
NT11277 - Standardizace diagnostických přístupů hypokortikalismu (2010-2015,MZ0/NT) Standardisation of diagnostic approche to hypercorticalism
Pelinková K.:
IGA NT 13531 Lidské mezenchymové stromální buňky pro léčebné účely. (2010-2015 MUDr R.Pytlík) Human mesenchymal stromal cells for therapeutic purposes. Preclinical and pharmacological testing and approval of the cellular product for clinical use.
Koštířová M.:
IGA –NS 10300-3(2010): Terapeutický a diagnostický potenciál hepcidínu(spolupráce). Therapeutic and diagnostic potential of hepcidin
IGA MZ ČR NT 11176-6 (2010 – 2014) Asociation of plateletes gene polymorphism with athretrombosis in patiens with venous tromboembolism - (co-investigator)
IGA MZ ČR NT 11210-4 (2010 – 2014) Influence of centrifugal pump on systemic inflammatory response and changes of blood elements in extracorporal circulation with deep hypothermia -( (co-investigator)
GA UK - 59410 (2010 – 2011) Monitoring of correlation of circulating tumour cells in blood (CTC) and disseminated tumour cells (DTC) in bone marrow in patients with primary breast carcinoma (co-investigator)
IGA MZ ČR NS10043-4/2008 Genetic predisposition and new biochemical markers of cardiovascular risk in patiens with chronic kidney diseases (co-investigator)
SVV-2010-260512 (2011): Regulatory mechanisms in pathogenesis of inflammatory and tumour diseases (co-investigator)
grant MPO FR-TI3/666, Assesment of pannel of new tumour markers in selected malignant diseases (co-investigator)
project BBMRI_CZ – development of Czech part of EU scientific infrastructure – Development and service of network of biological material banks for biomedical research. Responsible person
Research projects
prof. Tomáš Zima, MD, PhD, MBA:
RVO VFN 00064165: Diagnostics and treatment of genetic determinated diseases
VZ MSM002160849 (2007-2013) Neuropsychiatric aspects of neurodegenerative diseases
VZ MSM0021620807 – Metabolic, endocrine a genetic aspects of prevention, diagnotics and therapy of cardiovascular, cerebrovascular and renovascular diseases
PRVOUK P25/UK/1.LF UK – Complications of metabolic diseases
Springer D., Uhrová J.:
NT11277 - Standardizace diagnostických přístupů hypokortikalismu (2010-2015,MZ0/NT) Standardisation of diagnostic approche to hypercorticalism
Pelinková K.:
IGA NT 13531 Lidské mezenchymové stromální buňky pro léčebné účely. (2010-2015 MUDr R.Pytlík) Human mesenchymal stromal cells for therapeutic purposes. Preclinical and pharmacological testing and approval of the cellular product for clinical use.
Koštířová M.:
IGA –NS 10300-3(2010): Terapeutický a diagnostický potenciál hepcidínu(spolupráce). Therapeutic and diagnostic potential of hepcidin
04.01.2013 |
|
zpět na Projects and grants
